Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Haploidentical BMT With Post-Transplant Cyclophosphamide and Bendamustine
ClinicalTrials.gov study NCT02996773. IPD Sharing: Not stated. Countries: 1. Publications: 5.
p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian Cancer
ClinicalTrials.gov study NCT00844506. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
ClinicalTrials.gov study NCT00414128. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies
ClinicalTrials.gov study NCT00890955. IPD Sharing: Not stated. Countries: 1. Publications: 1.
High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis
ClinicalTrials.gov study NCT00939549. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00002501. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00083031. IPD Sharing: NO. Countries: 1. Publications: 1.
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
ClinicalTrials.gov study NCT00132522. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)
ClinicalTrials.gov study NCT02955810. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00070447. IPD Sharing: Not stated. Countries: 5. Publications: 0.
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Dox
ClinicalTrials.gov study NCT03467373. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Myeloma
ClinicalTrials.gov study NCT04119336. IPD Sharing: YES. Countries: 1. Publications: 0.
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
ClinicalTrials.gov study NCT01314833. IPD Sharing: NO. Countries: 1. Publications: 1.
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
ClinicalTrials.gov study NCT00293384. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy
ClinicalTrials.gov study NCT02139280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
ClinicalTrials.gov study NCT03945591. IPD Sharing: YES. Countries: 1. Publications: 0.
CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
ClinicalTrials.gov study NCT01740401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
ClinicalTrials.gov study NCT01253460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy
ClinicalTrials.gov study NCT00833560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT00305760. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.